Alligator Bioscience AB (publ) (STO:ATORX)

Sweden · Delayed Price · Currency is SEK

0.2405

+0.0200 (9.07%)

Apr 24, 2026, 5:29 PM CET

Revenue by Segment

Financials in millions SEK. Fiscal year is January - December.

Millions SEK. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016
Research and Development in The Field of Immunotherapy			59.25M	36.00M	13.33M	5.52M	4.36M
Research and Development in The Field of Immunotherapy Growth			64.58%	170.14%	141.65%	26.55%	-83.88%
Total			59.25M	36.00M	13.33M	5.52M	4.36M
Total Growth			64.58%	170.14%	141.65%	26.55%	-83.88%

Revenue by Geography

Financials in millions SEK. Fiscal year is January - December.

Millions SEK. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016
Finland			58.11M	35.70M	-	-	-
Finland Growth			62.78%	-	-	-	-
Sweden			-	-	3.52M	-	-
Europe			-	-	6.42M	-	-
Asia			-	-	2.09M	4.35M	4.29M
Asia Growth			-	-	-51.88%	1.49%	-82.99%
Other			-	-	908.00K	-	-
USA			-	-	-	-	70.00K
USA Growth			-	-	-	-	-95.93%
Total			58.11M	35.70M	12.94M	4.35M	4.36M
Total Growth			62.78%	175.79%	197.40%	-0.14%	-83.83%

Source: S&P Global Market Intelligence.